Sheffield KM - Search Results

1

Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions.

Sheffield KM, Dreyer NA, Murray JF, Faries DE, Klopchin MN. Sheffield KM, et al. J Comp Eff Res. 2020 Oct;9(15):1043-1050. doi: 10.2217/cer-2020-0161. Epub 2020 Sep 11. J Comp Eff Res. 2020. PMID: 32914653 Free article. Clinical Trial.

2

Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groups.

Sheffield KM, Bowman L, Smith DM, Li L, Hess LM, Montejano LB, Willson TM, Davidoff AJ. Sheffield KM, et al. J Comp Eff Res. 2018 Mar;7(3):193-208. doi: 10.2217/cer-2017-0040. Epub 2018 Mar 13. J Comp Eff Res. 2018. PMID: 29533694 Free article.

3

Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records.

Cui ZL, Kadziola Z, Lipkovich I, Faries DE, Sheffield KM, Carter GC. Cui ZL, et al. Among authors: sheffield km. J Comp Eff Res. 2021 Jun;10(9):777-795. doi: 10.2217/cer-2020-0230. Epub 2021 May 13. J Comp Eff Res. 2021. PMID: 33980048 Free article.

4

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer.

Aggarwal H, Han Y, Sheffield KM, Cui ZL. Aggarwal H, et al. Among authors: sheffield km. J Comp Eff Res. 2023 Feb;12(2):e220143. doi: 10.2217/cer-2022-0143. Epub 2023 Jan 27. J Comp Eff Res. 2023. PMID: 36705061 Free PMC article.

5

Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis.

Pappadis MR, Volk RJ, Krishnan S, Weller SC, Jaramillo E, Hoover DS, Giordano SH, Tan A, Sheffield KM, Housten AJ, Goodwin JS. Pappadis MR, et al. Among authors: sheffield km. BMJ Open. 2018 Jun 14;8(6):e022138. doi: 10.1136/bmjopen-2018-022138. BMJ Open. 2018. PMID: 29903800 Free PMC article.

6

Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data.

Beyrer J, Nelson DR, Sheffield KM, Huang YJ, Ellington T, Hincapie AL. Beyrer J, et al. Among authors: sheffield km. Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1465-1479. doi: 10.1002/pds.5137. Epub 2020 Oct 4. Pharmacoepidemiol Drug Saf. 2020. PMID: 33012044

7

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2- metastatic breast cancer.

Cuyun Carter G, Sheffield KM, Gossai A, Huang YJ, Zhu YE, Bowman L, Nash Smyth E, Mathur R, Cohen AB, Rasmussen E, Balakrishna S, Morato Guimaraes C, Rybowski S, Seidman AD. Cuyun Carter G, et al. Among authors: sheffield km. Curr Med Res Opin. 2021 Jul;37(7):1179-1187. doi: 10.1080/03007995.2021.1923468. Epub 2021 May 20. Curr Med Res Opin. 2021. PMID: 33970738

8

KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.

Goulding RE, Chenoweth M, Carter GC, Boye ME, Sheffield KM, John WJ, Leusch MS, Muehlenbein CE, Li L, Jen MH, Rojubally A, Jansen J, Druyts E. Goulding RE, et al. Among authors: sheffield km. Cancer Treat Res Commun. 2020;24:100200. doi: 10.1016/j.ctarc.2020.100200. Epub 2020 Jul 25. Cancer Treat Res Commun. 2020. PMID: 32750661 Free article.

9

Study of patient characteristics, treatment patterns, EGFR testing patterns and outcomes in real-world patients with EGFRm⁺ non-small cell lung cancer.

Winfree KB, Sheffield KM, Cui ZL, Sugihara T, Feliciano J. Winfree KB, et al. Among authors: sheffield km. Curr Med Res Opin. 2022 Jan;38(1):91-99. doi: 10.1080/03007995.2021.1983530. Epub 2021 Oct 12. Curr Med Res Opin. 2022. PMID: 34544302

10

Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting.

Price GL, Sudharshan L, Ryan P, Rajkumar J, Sheffield KM, Nash Smyth E, Morato Guimaraes C, Rybowski S, Cuyun Carter G, Gathirua-Mwangi WG, Huang YJ. Price GL, et al. Among authors: sheffield km. Curr Med Res Opin. 2022 Aug;38(8):1319-1331. doi: 10.1080/03007995.2022.2073122. Epub 2022 May 13. Curr Med Res Opin. 2022. PMID: 35535675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page